Cargando…
Pro-neural transcription factors as cancer markers
BACKGROUND: The aberrant transcription in cancer of genes normally associated with embryonic tissue differentiation at various organ sites may be a hallmark of tumour progression. For example, neuroendocrine differentiation is found more commonly in cancers destined to progress, including prostate a...
Autores principales: | Vias, Maria, Massie, Charlie E, East, Philip, Scott, Helen, Warren, Anne, Zhou, Zongxiang, Nikitin, Alexander Yu, Neal, David E, Mills, Ian G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413260/ https://www.ncbi.nlm.nih.gov/pubmed/18489756 http://dx.doi.org/10.1186/1755-8794-1-17 |
Ejemplares similares
-
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
por: Ramos-Montoya, Antonio, et al.
Publicado: (2014) -
The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
por: Sharma, Naomi L., et al.
Publicado: (2014) -
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
por: Massie, Charles E, et al.
Publicado: (2007) -
Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
por: Zecchini, Vincent, et al.
Publicado: (2014) -
Independence of HIF1a and androgen signaling pathways in prostate cancer
por: Tran, Maxine G. B., et al.
Publicado: (2020)